News
Important Only
Kymera Therapeutics rises after positive data for eczema drug
Shares of Kymera Therapeutics KYMR.O rise 5.6% to $70.32 premarketKYMR says its experimental oral treatment for eczema eased symptoms and itching in a small early-stage study, while also helping patients who had asthma or hay feverThe company tested the drug, KT-621, in 22 people with moderate-to-se...Reuters
Mon, Dec 8
Ocular Therapeutix rises on plans to fast-track FDA filing for eye disease drug
Shares of Ocular Therapeutix OCUL.O rise 13.5% to $14.28 in premarket tradingOCUL says its plans to submit a marketing application for its experimental eye disease drug, Axpaxli, to treat wet age-related macular degeneration after one-year data from its ongoing late-stage trial, expected in the firs...Reuters
Mon, Dec 8
NextEra Energy gains on Google deal expansion
Shares of utility NextEra Energy NEE.N up 2% at $84.74 premarketCo expands partnership with Google Cloud to scale multiple gigawatts (GW) of data center capacity and energy infrastructure across the U.S.Up to last close, stock was up ~16% YTDReuters
Mon, Dec 8
Marvell Technology falls after S&P 500 inclusion snub
Shares of chipmaker Marvell Technology MRVL.O drop 6.4% to $92.6 premarket Late on Friday, S&P Dow Jones Indices announced that Carvana CVNA.N, CRH CRH.Nand Comfort Systems USA FIX.N will join S&P 500 indexOn Friday, MRVL was one of the largest S&P 500 eligible new add by market capitali...Reuters
Mon, Dec 8
Stocks hold ground as markets eye Fed rate cut
LONDON/SYDNEY, Dec 8 (Reuters) - Stocks held their ground on Monday as markets bet that the Federal Reserve would deliver a rate cut this week, though investors speculated that the meeting could be one of the most fractious in recent memory.Reuters
Mon, Dec 8
Agios Pharma falls after FDA misses decision deadline on blood-disorder drug filing
Shares of drugmaker Agios Pharma AGIO.O fall 7.5% to $25.6 premarketAgios Pharmaceuticals says U.S. regulators have not yet made a decision on expanding the use of its rare blood disease drug mitapivat to patients with thalassemia, even though a target review date passed last weekThe drug mitapivat,...Reuters
Mon, Dec 8
Micron rises as brokerages raise PTs on AI-driven memory demand
Memory chipmaker Micron Technology's MU.O shares rise 2.5% to $243.13 premarketSusquehanna raises PT to $300 from $200 — implying an upside of 26.5% to the stock's last close — on stronger expected avg selling prices for dynamic random access memory and flash memory, driven by tight supply f...
Reuters
Mon, Dec 8
Lennar falls as Barclays cuts it to 'underweight'
Shares of U.S. homebuilder Lennar LEN.N down 1.5% at $122 premarketBarclays downgrades rating to "underweight" from "equal-weight", raises PT to $98 from $95New PT shows a downside of 20.9% from the stock's last closeBrokerage says co's rigid production model and high valuati...Reuters
Mon, Dec 8
JP Morgan changes PT and rating on energy cos citing supply risks
J.P. Morgan changes PT and rating on oil and gas companies citing supply side risks and long-awaited demand inflection for natural gasBrokerage says the magnitude of the oversupply plus the potential easing of geopolitical tensions would make this a speculative call at bestSees potential for global ...Reuters
Mon, Dec 8
Central bank body BIS raises concerns of gold and stocks double bubble
Central bank body BIS flags gold market concernsExplosive co-movement with stocks not seen for at least 50 yearsPoints to 'growing fragility' of risk-on environmentBy Marc Jones LONDON, Dec 8 (Reuters) - The combination of gold and share prices soaring in unison is a phenomenon not seen i...Reuters
Mon, Dec 8
Structure Therapeutics down ahead of weight-loss drug data
Shares of Structure Therapeutics GPCR.O falls 1.4% to $34.1 premarket The drug developer on December 8 is set to release data from a study evaluating its experimental drug aleniglipron, a once-daily oral for the treatment of obesityThe current landscape for obesity treatments includes Danish drugmak...Reuters
Mon, Dec 8
Incyte rises after antibody therapy shows potential in rare blood cancers
Shares of drugmaker Incyte INCY.O up 2.4% at $105 premarket INCY said on Sunday its experimental antibody therapy, INCA033989, showed significant reductions in spleen size and symptoms in patients with a type of rare blood cancerThe therapy is being tested in patients with myelofibrosis (MF), that s...Reuters
Mon, Dec 8
Coinbase's upcoming event potential near-term catalyst for stock, Clear Street says
Cryptocurrency exchange Coinbase's COIN.O upcoming event on December 17 could serve as a near-term catalyst, Clear Street saysBrokerage says COIN may unveil a coordinated expansion at the event, spanning consumer products, trading infrastructure, and global payments, all anchored in blockchainBr...Reuters
Mon, Dec 8
Dyne Therapeutics rises after positive data for its muscle wasting drug
Shares of drug developer Dyne Therapeutics DYN.O rise 16.8% to $23.69 premarketDYN's experimental drug zeleciment rostudirsen for the treatment of Duchenne muscular dystrophy (DMD) met the main goal in an early- to mid-stage trialIn a 32-patient study group that enrolled ambulant and non-ambulan...Reuters
Mon, Dec 8
Albemarle rises as Jefferies raises PT, citing higher EV demand
Shares of lithium miner Albemarle ALB.N up 4.3% at $130.58 premarketJefferies raises price target to $152 from $124, representing a premium of 21.4% to the stock's last closeBrokerage sees a "fragile equilibrium" in lithium through 2026–29, followed by a shift to meaningful deficits in t...Reuters
Mon, Dec 8
Arcellx surges after promising data from mid-stage cancer therapy trial
Shares of cancer therapy developer Arcellx ACLX.O jump 9.8% to $76.39 premarketCo announces positive mid-stage trial results for Anito-cel, an experimental cancer therapy for multiple myeloma, a type of blood cancerTherapy targets blood cancer that has relapsed and/or is not responding to treatmentF...Reuters
Mon, Dec 8
51Talk Online Education Group Announces New Share Repurchase Program
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that its board of directors has authorized a new share repurchase ...PR Newswire
Mon, Dec 8
US STOCKS-Wall St futures edge up as Fed interest rate cut decision nears
Futures up: Dow 0.02%, S&P 500 0.14%, Nasdaq 0.25% Dec 8 (Reuters) - U.S. stock index futures edged higher on Monday, supported by expectations that the Federal Reserve will deliver a long-awaited interest rate cut later this week at a meeting widely seen as one of the most divisive in recent...Reuters
Mon, Dec 8
PRECIOUS-Gold rises on Fed rate cut expectations, weaker dollar
Dollar near over one-month lows Silver hit a record high of $59.32/oz on FridayMarket price in 87% chance of Dec rate cut- CME FedWatchBy Pablo Sinha Dec 8 (Reuters) - Gold prices rose on Monday, driven by growing expectations of a U.S. interest rate cut that pressured the dollar, ahead of a Fed...Reuters
Mon, Dec 8
